HomeEducationRutgers doctors, University Hospital say use of COVID-19 survivors’ plasma presents ‘real...

Rutgers doctors, University Hospital say use of COVID-19 survivors’ plasma presents ‘real hope for saving lives’

Rutgers University physicians and University Hospital are making an appeal for blood donations from those who have survived COVID-19, saying their blood plasma contains antibodies that may help critically ill patients fight, and perhaps conquer, the virus.

The physicians, who received FDA approval Friday to use blood plasma from patients who recovered from COVID-19 to treat new patients, have thus far treated 17 patients with convalescent plasma. FDA approval is pending for the use of this treatment for additional patients.

Health care officials say the effectiveness of this treatment is not yet known, though similar treatment has been studied for Ebola and the MERS virus.

Marc Klapholz, chair of the department of medicine at Rutgers New Jersey Medical School and University Hospital and the principal investigator for the use of convalescent COVID-19 plasma, said there is promise.

“The use of convalescent plasma — blood plasma from individuals who have recovered from COVID-19 — presents real hope for saving lives,” Klapholz said.

University Hospital CEO Shereef Elnahal, the former state health commissioner, said he’s thrilled the Newark hospital is at the forefront of the trial of a technique that has been helpful in other outbreaks.

“In our battle against the COVID-19 virus, we are excited to be trialing this potential life-saving therapy in partnership with Rutgers New Jersey Medical School,” he said. “This treatment plan has been used for more than 100 years to address disease outbreaks for other conditions, and we’re optimistic that it will save lives.”

Elnahal and Klapholtz said they are hoping those who have survived the illness will step forward.

There certainly are plenty of potential donors. More than 50,000 people in New Jersey have survived COVID-19.

People interested in donating plasma must have had a confirmed positive test for COVID-19 from a lab or health facility and be eligible to donate blood. They can reach the Rutgers and University Hospital COVID-19 Treatment Group at 973-972-5474 or via email at covidplasma@uhnj.org.

Read more from ROI-NJ on coronavirus:

Related Articles

Rowan University, Holy Name agree to partner on nursing education

Rowan University and Holy Name’s Sister Claire Tynan School of Nursing on March 16 announced a dual enrollment partnership for students pursuing nursing education. The...

RWJBarnabas Health appoints Giantomasi to board, honors late Chair Berson

RWJBarnabas Health has appointed Francis J. Giantomasi, Esq., as a new member of its board of trustees, effective immediately, while also posthumously honoring late...

Grant supports 37 postdoctoral researchers at three Rutgers schools

Rutgers University has received a $1.5 million grant from the Gordon and Betty Moore Foundation to support 37 postdoctoral researchers across 12 scientific disciplines. The...

Rowan University and Gloucester County given $1.9M for research and roadwork

Rowan University and Gloucester County were given $1.9 million in community project funding to support the research, development and testing of concrete 3D-printed housing...

Finding the Right Pediatrician for Your Baby and Your Family

Choosing a pediatrician is one of the earliest and most important decisions you make as a parent. Many parents research online, read reviews, and...

Heights University Hospital readies for suspension of emergency services

Heights University Hospital, in anticipation of suspending emergency department services on Saturday, March 14, at 7:30 p.m., will continue to provide various community health...

Latest Articles

William Paterson University to expand MaCS Program with $2M grant from NSF

William Paterson University has been awarded a $2 million, six-year grant from the National Science Foundation (NSF) to continue and expand its Mathematics and...

Cushman & Wakefield arranges $56M construction loan for industrial development in Rahway

Cushman & Wakefield on March 16 announced that it has arranged a $56 million construction loan on behalf of Sagard Real Estate and Woodmont...

Wipro partners with Harness to accelerate AI-native software delivery

Wipro Limited, a leading AI-powered technology services and consulting company with a U.S. office in New Brunswick, and Harness, the AI Software Delivery Platform...

ACG New Jersey names 2026 Corporate Growth Awards honorees, taps Eric LeGrand

The Association for Corporate Growth New Jersey has announced the honorees for its 2026 Corporate Growth Awards, recognizing middle-market companies headquartered in New Jersey...
00:03:40

Steve Adubato’s Lessons in Leadership: Bill Noonan, chief business development officer, Choose NJ

As part of the Lessons in Leadership special series, “This is New Jersey,” Steve Adubato and Mary Gamba are joined by Bill Noonan, chief...

Astound names fiber executive Brandt CEO

Princeton-based Astound, a leader in Wi-Fi, mobile, TV and fiber‑optic solutions, announced that Ettienne Brandt has joined the company as chief executive officer, effective...

Latest Articles

William Paterson University to expand MaCS Program with $2M grant from NSF

William Paterson University has been awarded a $2 million, six-year grant from the National Science Foundation (NSF) to continue and expand its Mathematics and...

Cushman & Wakefield arranges $56M construction loan for industrial development in Rahway

Cushman & Wakefield on March 16 announced that it has arranged a $56 million construction loan on behalf of Sagard Real Estate and Woodmont...

Wipro partners with Harness to accelerate AI-native software delivery

Wipro Limited, a leading AI-powered technology services and consulting company with a U.S. office in New Brunswick, and Harness, the AI Software Delivery Platform...

ACG New Jersey names 2026 Corporate Growth Awards honorees, taps Eric LeGrand

The Association for Corporate Growth New Jersey has announced the honorees for its 2026 Corporate Growth Awards, recognizing middle-market companies headquartered in New Jersey...

Steve Adubato’s Lessons in Leadership: Bill Noonan, chief business development officer, Choose NJ

As part of the Lessons in Leadership special series, “This is New Jersey,” Steve Adubato and Mary Gamba are joined by Bill Noonan, chief...